NITHA JOSE: Open Payments
NPI 1205387115 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 38 payments from 13 companies in 2025. Trend: 2023 $401 · 2024 $352 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $301 |
| Paragonix Technologies, Inc. | 1 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $257 |
| Astellas Pharma US Inc | 1 | $125 |
| Baxter Healthcare | 5 | $111 |
| Grifols USA, LLC | 3 | $93 |
| United Therapeutics Corporation | 3 | $69 |
| ANI Pharmaceuticals, Inc. | 2 | $60 |
| Actelion Pharmaceuticals US, Inc. | 1 | $53 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
Products named: ARALAST, OFEV, JASCAYD, Cresemba, Hillrom - Vest System Model 105 Home Care, Prolastin-C Liquid, Tyvaso, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
